The paper said, citing senior investment bankers and industry sources, that informal conversations about a deal had taken place between the two firms but that no talks were currently under way after AstraZeneca resisted the approach.
Pfizer mulls $100 billion bid for AstraZeneca: Report
Pfizer said to be eyeing a $100 billion bid for AstraZeneca
The Pharma Letter
Related articles »